Splenectomy versus Rituximab as second line treatment of chronic ITP
Published: 4 October 2023| Version 1 | DOI: 10.17632/63n4sxg9hk.1
Contributors:
Rawand Shamoon, , Sarah AlnuaimiDescription
This data describes and compare response of chronic ITP patients to splenectomy and rituximab
Files
Institutions
Hawler Medical University College of Medicine
Categories
Adult Hematology